292605-11-9

Upstream product

• 915156-54-6 C₁₄H₁₂O₂S 
• 915156-52-4 C₁₅H₁₆O₅S 
• 198062-96-3 O-(4-phenoxyphenyl)-N,N-dimethylthiocarbamate 
• 198062-93-0 S-(4-phenoxyphenyl)-N,N-dimethylthiocarbamate 
• 831-82-3 4-Phenoxyphenol 
• 677709-60-3 1-chloro-3-[(4-phenoxyphenyl)sulfanyl]propan-2-ol 
• 38778-05-1 4-(Phenoxy)benzenethiol 
• 101-55-3 4-Bromodiphenyl ether 
• 677709-61-4 2-{[(4-phenoxyphenyl)sulfanyl]methyl}oxirane 
• 3159-49-7 3-(4-phenoxyphenylsulfanyl)-1-propene 

Downstream Products

• 292605-14-2 SB-3CT 

Relevant academic research and scientific papers

INHIBITORS OF MATRIX METALLOPROTEINASES

The present invention provides novel compounds of formulas I-IX, as described herein. Also provided are compositions of compounds of formulas I-IX, methods of making compounds of formulas I-IX, and methods of using compounds of formulas I-IX. The compounds of the invention can be used to inhibit matrix metalloproteinases, and are useful to treat conditions and diseases associated therewith.

INHIBITORS OF MATRIX METALLOPROTEINASES TO TREAT NEUROLOGICAL DISORDERS

The invention provides methods to treat neurological disorders, ophthalmological disorders, or a combination thereof by administering a compound that inhibits MMPs. A compound that inhibits MMPs is represented by the compound of formula (I) shown herein.

A Convenient Synthesis of a Selective Gelatinase Inhibitor as an Antimetastatic Agent

Compound 1, 2-(4-phenoxyphenylsulfonylmethyl)thiirane, is a potent and selective inhibitor for human gelatinases (J. Am. Chem. Soc. 2000, 122, 6799-6800), enzymes implicated in a number of diseases, including cancer. This compound is showing excellent pro

Inhibitors of matrix metallaproteinases

The invention provides compounds that inhibit MMPs; methods for treating or preventing cancer, angiogenesis, arthritis, connective tissue disease, cardiovascular disease, inflammation or autoimmune disease in a mammal; a method for inhibiting a matrix met